State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization. monoclonal antibody therapeutics: structure, function, and regulatory space / Volume 1 :
Saved in:
| Imprint: | Washington, DC : American Chemical Society, 2014. |
|---|---|
| Description: | 1 online resource (177 pages) : illustrations (some color). |
| Language: | English |
| Series: | ACS symposium series, 1947-5918 ; 1176 ACS symposium series ; 1176. |
| Subject: | |
| Format: | E-Resource Book |
| Local Note: | American Chemical Society, ACS Symposium Series eBooks - 2014 Front Files. |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/12570509 |
MARC
| LEADER | 00000nam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | 12570509 | ||
| 006 | m fo d | ||
| 007 | cr cn nnnauuuu | ||
| 008 | 180627s2014 dcua ob 101 0 eng d | ||
| 003 | ICU | ||
| 020 | |a 9780841230279 |q electronic | ||
| 024 | 8 | |a bk-2014-1176 | |
| 035 | |a (ACS)ccn00832191 | ||
| 040 | |a NjRocCCS |b eng |e rda |c NjRocCCS | ||
| 050 | 4 | |a QR186.85 |b .S73 2014 v.1 | |
| 060 | 4 | |a QW 575.5.A6 |b ST797 2014 v.1 | |
| 082 | 0 | 4 | |a 616.07/98 |2 23 |
| 084 | |a MED052000 |a MED044000 |2 bisacsh | ||
| 245 | 0 | 0 | |a State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization. |p Volume 1 : |b monoclonal antibody therapeutics: structure, function, and regulatory space / |c John E. Schiel, editor, National Institute of Standards and Technology, Gaithersburg, Maryland, Darryl L. Davis, editor, Janssen Research and Development, LLC, Spring House, Pennsylvania, Oleg V. Borisov, editor, Novavax, Inc., Gaithersburg, Maryland. |
| 246 | 3 | 0 | |a Monoclonal antibody therapeutics: structure, function, and regulatory space |
| 264 | 1 | |a Washington, DC : |b American Chemical Society, |c 2014. | |
| 300 | |a 1 online resource (177 pages) : |b illustrations (some color). | ||
| 336 | |a text |2 rdacontent |0 http://id.loc.gov/vocabulary/contentTypes/txt | ||
| 337 | |a computer |2 rdamedia |0 http://id.loc.gov/vocabulary/mediaTypes/c | ||
| 338 | |a online resource |2 rdacarrier |0 http://id.loc.gov/vocabulary/carriers/cr | ||
| 490 | 1 | |a ACS symposium series, |x 1947-5918 ; |v 1176 | |
| 500 | |a Distributed in print by Oxford University Press. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | 0 | |t Monoclonal Antibody Therapeutics: The Need for Biopharmaceutical Reference Materials / |r Schiel, John E., National Institute of Standards and Technology, Biomolecular Measurement Division, Gaithersburg, Maryland 20899, United States; Mire-Sluis, Anthony, North America, Singapore, Abingdon, Contract and Product Quality, Amgen Inc., Thousand Oaks, California 91320, United States; Davis, Darryl, Janssen Research and Development, LLC, Spring House, Pennsylvania 19002, United States / |u http://dx.doi.org/10.1021/bk-2014-1176.ch001 -- |t Monoclonal Antibodies: Mechanisms of Action / |r Jefferis, Roy / |u http://dx.doi.org/10.1021/bk-2014-1176.ch002 -- |t Heterogeneity of IgGs: Role of Production, Processing, and Storage on Structure and Function / |r Barton, Chris, Analytical Biotechnology, MedImmune, Gaithersburg, Maryland 20878, United States; Spencer, David, Analytical Biotechnology, MedImmune, Gaithersburg, Maryland 20878, United States; Levitskaya, Sophia, Analytical Biotechnology, MedImmune, Gaithersburg, Maryland 20878, United States; Feng, Jinhua, Analytical Biotechnology, MedImmune, Gaithersburg, Maryland 20878, United States; Harris, Reed, Genentech, Inc., South San Francisco, California 94080, United States; Schenerman, Mark A., Analytical Biotechnology, MedImmune, Gaithersburg, Maryland 20878, United States / |u http://dx.doi.org/10.1021/bk-2014-1176.ch003 -- |t Perspectives on Well-Characterized Biological Proteins / |r Brorson, Kurt, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, United States; Kendrick, Brent, Amgen Inc., Longmont, Colorado 80503, United States / |u http://dx.doi.org/10.1021/bk-2014-1176.ch004 -- |t Using Quality by Design Principles in Setting a Control Strategy for Product Quality Attributes / |r Flynn, Gregory C., Process and Product Development, Amgen Inc., Thousand Oaks, California 91320, United States; Nyberg, Gregg B., Drug Substance and Analytical Technologies, Amgen Inc., Longmont, Colorado 80503, United States / |u http://dx.doi.org/10.1021/bk-2014-1176.ch005 -- |t Appendix / |u http://dx.doi.org/10.1021/bk-2014-1176.ot001 -- |t Editors' Biographies / |u http://dx.doi.org/10.1021/bk-2014-1176.ot002 |
| 590 | |a American Chemical Society, ACS Symposium Series eBooks - 2014 Front Files. | ||
| 588 | |a Description based on publisher-supplied information and home-page. | ||
| 650 | 0 | |a Monoclonal antibodies. |0 http://id.loc.gov/authorities/subjects/sh85005650 | |
| 650 | 0 | |a Immunoglobulins |x Therapeutic use. | |
| 650 | 0 | |a Biopharmaceutics. |0 http://id.loc.gov/authorities/subjects/sh85014252 | |
| 650 | 0 | |a Monoclonal antibodies |x Mechanism of action. | |
| 650 | 0 | |a Immunoglobulins |x Structure |x Analysis. | |
| 650 | 0 | |a Proteins |x Analysis. |0 http://id.loc.gov/authorities/subjects/sh85107668 | |
| 650 | 0 | |a Monoclonal antibodies |x Quality control. | |
| 650 | 1 | 2 | |a Antibodies, Monoclonal. |
| 650 | 1 | 2 | |a Immunoglobulins |x therapeutic use. |
| 650 | 1 | 2 | |a Biopharmaceutics. |
| 650 | 1 | 2 | |a Antibodies, Monoclonal |x metabolism. |
| 650 | 1 | 2 | |a Immunoglobulins |x analysis. |
| 650 | 1 | 2 | |a Proteins |x analysis. |
| 650 | 7 | |a MEDICAL / Microbiology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Immunology. |2 bisacsh | |
| 700 | 1 | |a Schiel, John E., |e editor. |u National Institute of Standards and Technology, Gaithersburg, Maryland. |0 http://id.loc.gov/authorities/names/no2009114287 |1 http://viaf.org/viaf/91190637 | |
| 700 | 1 | |a Davis, Darryl L., |e editor. |u Janssen Research and Development, LLC, Spring House, Pennsylvania. |0 http://id.loc.gov/authorities/names/n2014062930 |1 http://viaf.org/viaf/310714992 | |
| 700 | 1 | |a Borisov, Oleg, |e editor. |u Novavax, Inc., Gaithersburg, Maryland. |0 http://id.loc.gov/authorities/names/no2011126776 |1 http://viaf.org/viaf/175703002 | |
| 710 | 2 | |a American Chemical Society, |e issuing body. |0 http://id.loc.gov/authorities/names/n78088941 |1 http://viaf.org/viaf/143644441 | |
| 776 | 1 | |c Original |z 9780841230262 (alk. paper) | |
| 776 | 1 | |c Online version |w (OCoLC)899450267 | |
| 830 | 0 | |a ACS symposium series ; |v 1176. |x 1947-5918 | |
| 856 | 4 | 0 | |u https://pubs.acs.org/doi/book/10.1021/bk-2014-1176 |y ACS |
| 903 | |a HeVa | ||
| 929 | |a eresource | ||
| 999 | f | f | |i 8bd2cab4-ab2d-54cd-baf4-05a0759a9f36 |s 57c5e62c-abb5-533d-ad07-634b76ba0f9c |
| 928 | |t Library of Congress classification |a QR186.85 .S73 2014 v.1 |l Online |c UC-FullText |u https://pubs.acs.org/doi/book/10.1021/bk-2014-1176 |z ACS |g ebooks |i 12492657 | ||